Brief: Fulgent Genetics Q3 Revenue USD 19 Million
03/11/2023 11:00
Nov 03 (Reuters) - Fulgent Genetics Q3 adjusted EBITDA USD 18.1 million. * Q3 core revenue USD 66 million
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview